Lefebvre Eric's Insider Trades & SAST Disclosures
Lefebvre Eric's most recent trade in Pliant Therapeutics Inc was a trade of 91,300 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lefebvre Eric.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 91,300 | 91,300 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 45,650 | 240,224 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 18,478 | 194,574 | - | 11.2 | 206,974 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.56 per share. | 10 Jul 2024 | 12,319 | 213,052 | - | 11.6 | 142,408 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 24,063 | 225,371 | - | 0 | Common Stock | |
| Cymabay Therapeutics Inc | Eric Lefebvre | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 115,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Eric Lefebvre | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Eric Lefebvre | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 14,010 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Eric Lefebvre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,010 | 14,010 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Lefebvre Eric | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 85,800 | 85,800 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 42,900 | 199,820 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Lefebvre Eric | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.23 per share. | 17 Jan 2024 | 10,295 | 156,920 | - | 17.2 | 177,383 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 17 Jul 2023 | 22,321 | 167,215 | - | 18.0 | 401,981 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 43,750 | 189,536 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.52 per share. | 30 Mar 2023 | 11,245 | 145,786 | - | 26.5 | 298,228 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 21,874 | 157,031 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 57,000 | 133,926 | - | 0 | Common Stock | |
| Cymabay Therapeutics Inc | Eric Lefebvre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.48 per share. | 23 Jan 2023 | 67,500 | 76,926 | - | 34.5 | 2,327,630 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 21,876 | 155,313 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.10 per share. | 19 Dec 2022 | 10,887 | 144,426 | - | 19.1 | 207,968 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 25 Oct 2022 | 5,000 | 133,437 | - | 25.0 | 125,241 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 11 Jul 2022 | 3,000 | 138,436 | - | 20 | 60,000 | Common Stock |
| Cymabay Therapeutics Inc | Eric Lefebvre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.62 per share. | 18 Jun 2021 | 8,750 | 140,830 | - | 28.6 | 250,438 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.43 per share. | 18 Jun 2021 | 3,728 | 137,102 | - | 29.4 | 109,718 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 18 Jun 2021 | 22 | 137,080 | - | 30.2 | 665 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.38 per share. | 18 Mar 2021 | 11,365 | 150,715 | - | 39.4 | 447,528 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.78 per share. | 18 Mar 2021 | 1,135 | 149,580 | - | 39.8 | 45,150 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2021 | 73,250 | 73,250 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.17 per share. | 18 Dec 2020 | 6,788 | 167,792 | - | 26.2 | 177,642 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.98 per share. | 18 Dec 2020 | 5,712 | 162,080 | - | 27.0 | 154,110 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges